• Home
  • About
  • Categories
    • Lymphatic Imaging & Lymphedema
    • Pyoderma Grangrenosum
    • The COVID-19 Diaries
    • Dr. Marissa Carter
    • Regulatory and Coverage Policy
    • Do the Right Thing
    • Don’t Miss This
    • Fight the Good Fight
    • Health IT & Wound Care
    • Healthcare Payment Policy
    • Miscellaneous Musings
    • Articles on PRESENT Podiatry
    • Editorials in Today’s Wound Clinic
    • Nutrition & Wound Healing
    • Pressure Cooker: Rethinking Pressure Ulcers
    • Quality Payment Program
    • US Wound Registry
  • Contact
  • Facebook
  • LinkedIn
I am a Crybaby and the Wound Care Evidence Summit April 1-2 (Part 3)

I am a Crybaby and the Wound Care Evidence Summit April 1-2 (Part 3)

by Caroline Fife, M.D. | Feb 28, 2020 | Fight the Good Fight, Healthcare Payment Policy, US Wound Registry

The Wound Care Evidence Summit will take place in Washington, D.C. April 1-2.  If you are involved in this area, you need to register now because spots are limited. The meeting will convene commercial and government payer medical directors, the FDA, NIH senior staff,...
Check Out the Standardized “Reason” Codes for Denial of Payment for HBOT

Check Out the Standardized “Reason” Codes for Denial of Payment for HBOT

by Caroline Fife, M.D. | Feb 26, 2020 | Healthcare Payment Policy, Hyperbaric Oxygen Therapy

Medicare review contractors (Medicare Administrative Contractors, Recovery Audit Contractors and the Supplemental Medical Review Contractor) develop and maintain lists of reasons for denying payment for Medicare covered services like hyperbaric oxygen therapy (HBOT)....
Kafkaesque Clinical Trials – and Why You Need to Attend the Wound Care Evidence Summit (Part 2)

Kafkaesque Clinical Trials – and Why You Need to Attend the Wound Care Evidence Summit (Part 2)

by Caroline Fife, M.D. | Feb 26, 2020 | Fight the Good Fight, Healthcare Payment Policy

The Wound Care Evidence Summit will take place in Washington, D.C. April 1-2.  If you are involved in this area, you need to register now because spots are limited. The meeting will convene commercial and government payer medical directors, the FDA, NIH senior staff,...
Kafkaesque Clinical Trials – and Why You Need to Attend the Wound Care Evidence Summit April 1-2 (Part 1)

Kafkaesque Clinical Trials – and Why You Need to Attend the Wound Care Evidence Summit April 1-2 (Part 1)

by Caroline Fife, M.D. | Feb 25, 2020 | Fight the Good Fight, Healthcare Payment Policy

The Wound Care Evidence Summit will take place in Washington, D.C. April 1-2.  If you are involved in this area, you need to register now because spots are limited. The meeting will convene commercial and government payer medical directors, the FDA, NIH senior staff,...
The (Surrogate) Wound Outcomes that CMS Doesn’t Really Care About

The (Surrogate) Wound Outcomes that CMS Doesn’t Really Care About

by Caroline Fife, M.D. | Feb 24, 2020 | Fight the Good Fight, Healthcare Payment Policy, US Wound Registry

There’s a big focus on finding surrogate measures for wound outcome. I thought I could save anyone working in this area some wasted time by letting you know what outcomes CMS doesn’t care about. I can’t speak to what the FDA might care about. Under the Merit Based...
A Dirty Little Secret About Social Determinants and Access to Cellular and/or Tissue-Based Products (CTPs)

A Dirty Little Secret About Social Determinants and Access to Cellular and/or Tissue-Based Products (CTPs)

by Caroline Fife, M.D. | Feb 20, 2020 | Cellular / Tissue-Based Products, Healthcare Payment Policy

I feel like I should start this blog like the beginning of Star Wars, “Long ago, in a galaxy far away…“ Back in 2013, when insurance was less complicated, the US Wound Registry provided data for a medical student project under the supervision of Dr. Adelaide...
A Peek at Real World Use of Cellular and/or Tissue Based Product (CTP) Use – On the Eve of Episode-Based Payment

A Peek at Real World Use of Cellular and/or Tissue Based Product (CTP) Use – On the Eve of Episode-Based Payment

by Caroline Fife, M.D. | Feb 19, 2020 | Healthcare Payment Policy

To assist the Alliance of Wound Care Stakeholders in making its comments to CMS about the proposed “episode of care” payment model for Cellular and/or Tissue Based Products (CTPs) – sometimes referred to as “skin substitutes,” the US Wound Registry...
Why Quality of Life Failed Miserably as a Surrogate Endpoint for Wound Outcome

Why Quality of Life Failed Miserably as a Surrogate Endpoint for Wound Outcome

by Caroline Fife, M.D. | Feb 18, 2020 | Health Information Technology and Wound Care, Healthcare Payment Policy

There is lot of interest in surrogate measures of wound outcome to capture important aspects of treatment beyond closure. Because it provides insight into the patient’s experience, Quality of life (QOL) is an obvious surrogate for healing rate. For your own safety,...
The “Potemkin Village” of Wound Management and the Wounds with No Name

The “Potemkin Village” of Wound Management and the Wounds with No Name

by Caroline Fife, M.D. | Feb 17, 2020 | Healthcare Payment Policy

In 1787, Catherine II (also known as Catherine the Great), a Russian Tsarina, set out on a tour of the Crimea, an area Russia had annexed from the Ottoman Empire. The area had been devastated by the Crimean War and was a mess. Grigory Potemkin, governor of the Crimea,...
Bad News on an HBOT Audit

Bad News on an HBOT Audit

by Caroline Fife, M.D. | Feb 14, 2020 | Healthcare Payment Policy, Hyperbaric Oxygen Therapy

I was asked to take a look at a 50-page report on a wound center’s post-payment review of hyperbaric oxygen therapy (HBOT) services. Nearly all the wounds that were treated were truly limb-threatening, and most of the patients got better. Unfortunately, their...
« Older Entries
Next Entries »
Wound Care Reimbursements

Recent Articles

  • What I’d Fix About MIPS if I Were Queen June 6, 2025
  • Site Neutrality – a Looming Disaster or an Opportunity? June 5, 2025
  • Well-Known Wound Care Practitioner Jay Shah, President of the Texas Medical Association “Let Doctors be Doctors” Podcast June 4, 2025
  • Thank You to the WOCN for Asking Me to Provide an Update on the “Skin Substitute” Market! June 2, 2025
  • CMS Suspends 8 MIPS Improvement Activities May 30, 2025

Article Categories

  • Cassandra Chronicles: Regulatory and Coverage Policy
  • Cellular / Tissue-Based Products
  • COVID-19
  • COVID-19 & HBOT
  • COVID-19 Diaries
  • CTP / Skin Substitute Arrests
  • CTP / Skin Substitutes
  • Do the Right Thing: Thoughts on Quality
  • Don't Miss This
  • Dr. Helen Gelly
  • Dr. Marissa Carter
  • Events
  • Featured
  • Fight the Good Fight
  • Guide to the Lymphatic System
  • Health Information Technology and Wound Care
  • Healthcare Payment Policy
  • Hyperbaric Oxygen Therapy
  • If I Were Queen
  • Lymphatic Imaging & Lymphedema
  • Medicare Audits
  • Miscellaneous Musings
  • Nutrition & Wound Healing
  • PAD Hall of Shame
  • Patient's Perspective
  • Pressure Cooker: Rethinking Pressure Ulcers
  • Pyoderma Gangrenosum
  • Quality Payment Program
  • Quiz / Survey
  • SAWC
  • Shin Radiation Madness
  • Skin Perfusion Pressure (SPP)
  • Tales of the Medicare Disadvantaged
  • The Patient's Voice
  • Uncategorized
  • Undaunted Spirit Award
  • US Wound Registry

Articles by Month

  • Facebook
  • X
©2024 Dr. Caroline Fife M.D. All rights reserved. Website design & programming by LI Web Guy Inc.